Ghosh S, Janocha AJ, Aronica MA, et al
Research on IV versus oral NAD+ precursors shows similar blood NAD+ increases
Background Medicare Part B covers many cellular immunotherapies and gene therapies that are FDA-approved under a biologics license application (BLA) as incident to drugs and biologicals under section 1861(s)(2) of the Act, which are paid under section 1847A of the Act (typically, at ASP plus 6 percent)
But heres what we know from recent research: A 2025 study presented at ENDO showed that postmenopausal women using tirzepatide plus hormone replacement therapy (HRT) lost significantly more weight (17% total body weight) compared to women using tirzepatide alone (14%)
These concordant effects on mediators of cardiorenal benefits support the hypothesis that physiological mechanisms of cardiorenal protection may also be pertinent in individuals with type 1 diabetes treated with SGLT2i
Research suggests that eating 2540 grams of protein at each meal is more effective for muscle maintenance than eating a small amount at breakfast and lunch and a large amount at dinner
